About
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease. Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world. Our results will benefit customers, patients, employees, and shareholders. We will celebrate our successes, thrive on discovery, and continually expand our boundaries. We will act boldly, decisively, and with determination on behalf of people fighting cardiovascular disease.
Top Deals
SOLD
Share this deal
California | Office | PPSF: $142
01/21/2026
Focus
Sale
Markets
FAQs
Edwards Lifesciences has financed 1 deal.
Edwards Lifesciences's most recent deal was on January 21, 2026.
Edwards Lifesciences's largest deals include a sale of $19,000,000.00 for 16225 Alton Parkway.
Member since: January 2026
Deals
Transaction Type
Asset Type
State
Sort By
SOLD
Bernard Zovighian Of Edwards Lifesciences Acquires Alton Corporate Center In Irvine For $19M
$142/SF
16225 Alton Parkway, Irvine, CA
CACRE
Jan 21, 2026